Body Myositis Study

Neurology Now
September/October 2007
Volume 3(5)
p 11
Back to top

THE EDITOR RESPONDS: Thank you for your letter, Jennifer. We hope this announcement helps your recruiting efforts.

MYOSITIS TRIAL

To enroll in the Rituximab in Myositis (RIM) study, please contact the coordinating center at 412-647-3241 or visit the RIM study Web site at RimStudy.org .

Back to top